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ABSTRACT
Insulin-like growth factor-1 (IGF-1) is a growth factor with
differentiating, anti-apoptotic and metabolic functions in the
periphery, and anti-inflammatory properties in the nervous system.
Mice that have mutations in the Igf1 gene, rendering the gene product
inactive (Igf1−/−), present with age-related visual loss accompanied by
structural alterations in the first synapses of the retinal pathway.
Recent advances have revealed a crucial role of autophagy in
immunity and inflammation. Keeping in mind this close relationship,
weaimed to decipher theseprocesses in the context of the defects that
occur during ageing in the retina of Igf1−/−mice.Tnfa and Il1bmRNAs,
and phosphorylation of JNK and p38 MAPK were elevated in the
retinas of 6- and 12-month old Igf1−/−mice compared to those in age-
matched Igf1+/+ controls. In 6-month-old Igf1−/− retinas, increased
mRNA levels of the autophagymediatorsBecn1,Atg9,Atg5 andAtg4,
decreased p62 (also known as SQSTM1) protein expression together
with an increased LC3-II:LC3-I ratio reflected active autophagic flux.
However, in retinas from 12-month-old Igf1−/− mice, Nlrp3 mRNA,
processing of the IL1β pro-form and immunostaining of active
caspase-1 were elevated compared to those in age-matched Igf1+/+
controls, suggesting activation of the inflammasome. This effect
concurred with accumulation of autophagosomes and decreased
autophagic flux in the retina. Microglia localization and status of
activation in the retinas of 12-month-old Igf1+/+ and Igf1−/− mice,
analyzed by immunostaining of Cd11b and Iba-1, showed a specific
distribution pattern in the outer plexiform layer (OPL), inner plexiform
layer (IPL) and inner nuclear layer (INL), and revealed an increased
number of activated microglia cells in the retina of 12-month-old blind
Igf1−/−mice.Moreover, reactive gliosiswas exclusively detected in the
retinas from 12-month-old blind Igf1−/−mice. In conclusion, this study
provides new evidence in a mouse model of IGF-1 deficiency that
autophagy is an adaptive response that might confer protection
against persistent inflammation in the retina during ageing.
KEY WORDS: Autophagy, IGF-1, Neurodegeneration,
Neuroinflammation, Retina
INTRODUCTION
Insulin-like growth factor-1 (IGF-1) is a growth factor with
differentiating, anti-apoptotic and metabolic functions in the
periphery (Shaw and Grant, 2004; Laviola et al., 2007). IGF-1 is
synthesized and secreted by the liver in response to increased
concentrations of growth hormone (GH). Concentrations of
circulating IGF-1 vary at different developmental stages,
increasing during periods of growth such as puberty and
decreasing with ageing (Clark et al., 1998; Lacau-Mengido et al.,
2000). IGF-1 actions are mediated by the IGF-1 receptor (IGF1R),
which belongs to the tyrosine kinase membrane receptor family, of
which the insulin receptor is the prototype (Werner and LeRoith,
2014). In the nervous system, IGF-1 has a role as a neurotrophic
peptide, triggering pro-survival signalling that activates anti-
apoptotic cascades, enhances nerve growth and promotes synaptic
plasticity. In addition, anti-inflammatory properties have been
attributed to IGF-1 (Hu et al., 2015). All these functions are
essential for protecting nerve cells against neurodegenerative
processes (Varela-Nieto et al., 2013; Yamamoto et al., 2014). In
fact, IGF-1 resistance in the central nervous system (CNS) impairs
neuroprotection in Alzheimer (Steen et al., 2005) and Parkinson
diseases (Trejo et al., 2004). Individuals with homozygous
mutations of the IGF1 gene exhibit microcephaly, mental
retardation and bilateral sensorineural deafness (Woods et al.,
1996; Walenkamp et al., 2005; Walenkamp and Wit, 2007). The
therapeutic potential of IGF-1 has been demonstrated in animal
models of a number of neurodegenerative diseases such as
cerebellar ataxia (Fernandez et al., 2005), multiple sclerosis
(Chesik et al., 2007) and, as mentioned above, Parkinson disease
(Ebert et al., 2008) and Alzheimer disease (Fernandez and Torres-
Aleman, 2012), in which treatment with IGF-1 alleviates
neurological symptoms.
Age-related loss of sensory activity represents a costly and
socially debilitating aspect in general senescence of the CNS. Our
previous studies in mice that lacked Igf1 have demonstrated that
these mice present congenital sensorineural deafness and age-
related metabolic cochlear alterations (Camarero et al., 2001; Cediel
et al., 2006; Riquelme et al., 2010; Sanchez-Calderon et al., 2010).
Moreover, mice deficient in IRS2 (Irs2−/−), a downstream docking
molecule of the IGF1R signaling cascade, also exhibit congenital
sensorineural deafness, which can be detected before the onset of
diabetes, that is characterized by altered cochlear morphology with
hypoinnervation of the cochlear ganglion and aberrant stria
vascularis (Murillo-Cuesta et al., 2012). Interestingly, some of the
alterations in the gene expression profile found in Igf1−/− mice are
related to retinal development (Sanchez-Calderon et al., 2010).
These results were confirmed by analysis of visual function, which
revealed a loss of vision over time in Igf1−/−mice with a very small
amplitude in the electroretinogram (ERG) waves at the age of
12 months (Rodriguez-de la Rosa et al., 2012). Importantly, theReceived 23 May 2016; Accepted 4 July 2016
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de Anatomıá y Biologıá Celular and IDIVAL, Universidad de Cantabria, 39011,
Santander, Spain.
*Authors for correspondence (aarroba@iib.uam.es; avalverde@iib.uam.es)
A.I.A., 0000-0002-5136-1725
This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution and reproduction in any medium provided that the original work is properly attributed.
965
© 2016. Published by The Company of Biologists Ltd | Disease Models & Mechanisms (2016) 9, 965-974 doi:10.1242/dmm.026344
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
defect in visual function is accompanied by a significant loss of cell
contacts in the outer plexiform layer (OPL) between the
photoreceptors and their postsynaptic bipolar and horizontal cells.
However, the molecular events that compromise retinal structure
and visual function in Igf1−/− mice during ageing have not been
investigated in depth.
During chronic diseases of the retina, a close association between
neurodegeneration and neuroinflammation has been reported. In the
CNS, microglial cells comprise the resident phagocyte population,
and have important roles in immune surveillance as well as in
neuronal homeostasis (Hanisch, 2002; Streit, 2002, 2005).
Activated microglia can exert both protective and deleterious
functions. In the early phase of neurodegeneration, microglia
participate in tissue remodelling and initiate repair mechanisms,
such as those during glial scar formation. However, in the CNS,
excessive or prolonged activation of microglia, particularly in the
retina, leads to chronic inflammation with severe pathological side
effects, often resulting in irreversible retinal degeneration (Graeber
and Streit, 2010). Interestingly, age-related disorders in the CNS
have been attributed to chronic neuroinflammation that results from
persistent activation of microglia (Caldeira et al., 2014).
Among the potential biological processes that alleviate
neuroinflammation-induced cellular damage, autophagy plays
a key role because it is a catabolic process that sequesters
components of the cytoplasm, including aberrant organelles and
macromolecules, into double-membraned vesicles and delivers them
to lysosomes for degradation, leading to eventual recycling of the
resulting macromolecules (Klionsky et al., 2016). Autophagy
influences the physiology and pathology of many immune cells,
including those of microglia. For instance, it has been recently
reported that autophagy in microglia degrades extracellular
β-amyloid fibrils and regulates the NLRP3 inflammasome (Cho
et al., 2014). Moreover, activation of the autophagy process
mitigates the expression of proinflammatory cytokines and the cell
death of BV2 mouse microglial cells that have been challenged with
bacterial lipopolysaccharide (Han et al., 2013). Keeping in mind this
close relationship between neuroinflammation and autophagy, our
aim in this studywas to decipher these processes in the context of the
retinal defects that occur during ageing in Igf1−/− mice.
RESULTS
Igf1 deficiency increases retinal inflammatory markers
Based on our previous study in wild-type (Igf1+/+) and Igf1−/−mice
(Rodriguez-de la Rosa et al., 2012), we first evaluated inflammation
in the retina in those mice at two distant ages; 6 months (referred to
in figures as young, Y) with unaltered visual function and
12 months (referred to in figures as old, O) at which there was
profound loss of vision. As shown in Fig. 1A, elevations in Tnfa and
Il1b mRNAs were found in the retinas of Igf1−/− mice at both ages
compared to the values of their respective age-matched wild-type
(Igf1+/+) counterparts. Of note, mRNA levels of Il6 were not
detected in the retinas of both genotypes of mice (results not
shown). Moreover, we analyzed mRNA levels of Nos2 as a marker
of the M1 macrophage proinflammatory response and Arg1 mRNA
(encoding arginase-1), a marker of the M2 macrophage anti-
inflammatory response, and no differences among groups were
found (Fig. 1B).
We also evaluated the impact of Igf1 deficiency in the activation
of proinflammatory signaling pathways in the retina. As Fig. 2A,B
shows, increased phosphorylation of JNK and p38 MAPK was
found in young and old Igf1−/−mice compared to their age-matched
Igf1+/+ counterparts, reflecting chronic inflammation in these mice
at both ages. Two-way ANOVA analysis revealed significant
differences among genotypes (Igf1−/− vs Igf1+/+) at each age, but
not when comparing the responses at the two different ages (old vs
young) within each genotype.
Autophagy flux is activated in the retina from young Igf1−/−
mice
Recently, autophagy has emerged as a biological process related to
inflammation in different cellular contexts because it targets the
inflammasome components for degradation (Harris, 2011; Shi et al.,
2015). On that basis, we hypothesized that differences in autophagy
could explain the differences between young and old Igf1−/−mice in
the retinal structure and visual function that have already been
detected (Rodriguez-de la Rosa et al., 2012). The mRNA levels of
autophagy mediators, such as Becn1, Atg9, Atg5 and Atg4, were
significantly elevated in young Igf1−/− retinas compared to in the
age-matched Igf1+/+ controls (Fig. 3A). As lipidation of LC3 is a
useful marker for autophagy, we analyzed LC3 by western blotting,
and we detected a significant increase in the LC3-II:LC3-I ratio
(2.3-fold) in the retinas from young Igf1−/− mice as compared with
that in age-matched Igf1+/+ controls (Fig. 3B). Increased LC3-II
indicates an accumulation of autophagosomes, which does not
always mean the upregulation of the autophagic flux (Klionsky
et al., 2016). Thus, autophagic function was evaluated by analysing
protein levels of p62 (also known as SQSTM1), a selective substrate
of autophagy, because activation of the autophagic flux is associated
with a decline in p62 protein levels, and vice versa (Bjorkoy et al.,
2005). As Fig. 3B shows, a significant decrease in p62 was detected
Fig. 1. Analysis of proinflammatory markers in the retinas from Igf1−/−
mice during ageing. Tnfa, Il1b (panel A), Nos2 and Arg1 (panel B) mRNA
levels in young (Y) and old (O) Igf1−/− and Igf1+/+ mice matched at each age.
Results are means±s.e.m. (n=5 retinas per experimental condition). The fold
change relative to Igf1+/+ (Y) is shown. *P≤0.05, Igf1−/− vs Igf1+/+ mice
matched at each age (two-way ANOVA followed by Bonferroni t-test).
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in young Igf1−/− retinas, reflecting an active autophagic flux at
this age. To inspect the signaling pathways involved in autophagy,
we evaluated the activation of mammalian target or rapamycin
(mTOR) as a well-established signaling mediator of autophagy.
The data in Fig. 3B show that there were no differences in
mTOR phosphorylation levels in the retina of the two genotypes of
mice.
Analysis of the inflammasome in the retina of Igf1−/−mice
during ageing
To elucidate the involvement of the inflammasome system in retinal
inflammation in Igf1−/− mice, we analyzed the expression of
caspase-1, a key component of the inflammasome that is responsible
for IL1β processing. Neither active caspase-1 (Fig. S1A) nor
processing of IL1β (results not shown) were detected in the
retinas of young Igf1−/−mice. In agreement with this, no differences
were found in the mRNA levels of Nlrp3 in the retinas from young
Igf1+/+ and Igf1−/− mice (Fig. S1B).
Next, we evaluated the activation status of microglia and their
localization in the retina by performing double immunofluorescence
analysis for Cd11b and Iba-1. Specific immunolabelling for the
microglia markers Iba-1 and Cd11b was detected in the retinas from
young Igf1+/+ and Igf1−/− mice, and the quantification of the
number of immunolabelled cells was similar in both experimental
groups (Fig. S1C). Likewise, we did not find differences in Iba-1
protein expression between young Igf1+/+ and Igf1−/− mice (results
not shown).
As found in young mice (Fig. S1B), the analysis of the
inflammasome system in the retinas of old mice that lacked Igf1
revealed increased mRNA levels ofNlrp3 compared to those in their
respective age-matched Igf1+/+ controls (Fig. 4A). Two-way
ANOVA analysis revealed significant differences in Nlrp3 mRNA
levels across genotypes (Igf1−/− vs Igf1+/+) in both young
(Fig. S1B) and old (Fig. 4A) mice, but not in the responses
compared between the two ages (old vs young) within each
genotype (data not shown). This elevation correlated with the
processing of the IL1β pro-form given that its levels were
significantly decreased in Igf1−/− mice (Fig. 4B); however, we
were unable to detect the IL1β active fragment in retinal extracts. As
expected, the immunofluorescence analysis of retinal sections in old
Igf1−/− mice showed higher levels of active caspase-1, mainly
localized in the INL, compared to age-matched Igf1+/+ controls
(Fig. 4C), indicating the activation of the inflammasome. These
results indicate that in old Igf1−/− mice, neuroinflammation in the
retina concurs with activation of the inflammasome and the loss of
visual function.
Because a switch in the activation status of microglia has been
described in experimentally-induced stress and in animal models of
neurodegenerative diseases (Streit, 2005), we next evaluated
microglia localization and the status of activation in the retinas of
old Igf1+/+ and Igf1−/−mice by performing double Cd11b and Iba-1
immunostaining. Cd11b preferentially labels ramified resting
microglia (both recruited and local), whereas Iba-1 preferentially
labels amoeboid-activated microglia. The quantification of Iba-1
immunopositive microglial cells revealed a significant increase of
that in the retinas from old Igf1−/− mice as compared with age-
matched Igf1+/+ controls, which exhibited a specific distribution in
the outer plexiform layer (OPL), inner plexiform layer (IPL) and
inner nuclear layer (INL) (Fig. 5A). This result was confirmed by
western blot analysis of Iba-1 protein expression in retinal extracts
(Fig. 5B). Two-way ANOVA analysis of the number of Iba-1
positive microglial cells in young (Fig. S1C) and old (Fig. 5A) mice
revealed significant differences between the genotypes (Igf1−/− vs
Igf1+/+) only in old mice (data not shown). When comparisons were
made between ages (old vs young), significant differences were
found within each genotype (data not shown).
Autophagy declines with ageing in the retina of Igf1−/−mice
Opposite to our observations in young mice (Fig. 3), mRNA
levels of Becn1, Atg9, Atg5 and Atg4were similar in old Igf1+/+ and
Igf1−/− mice (Fig. 6A). Two-way ANOVA analysis revealed all
these autophagy-related genes significantly decreased with ageing
exclusively in Igf1−/− mice. At this age, retinas from old Igf1−/−
mice showed higher p62 protein levels than those of the Igf1+/+
controls, whereas similar LC3-II:LC3-I ratios were found in the
retinas of both genotypes (Fig. 6B), indicating a decrease of the
autophagic flux in retinas that lacked Igf1. Moreover, increased
levels of phosphorylation of mTOR reinforced the blockade of
Fig. 2. Activation of stress-kinase-mediated
signaling in the retinas of Igf1−/− mice. Protein
extracts (30 μg) from retinas from young (Y) and
old (O) (panels A and B, respectively) Igf1−/− and
Igf1+/+ mice were separated by SDS-PAGE and
analyzed by western blotting with antibodies
against phosphorylated (p)-JNK, total JNK,
phosphorylated (p)-p38 MAPK and total p38
MAPK. Two samples from different mice are shown
for each genotype and age. Representative
autoradiograms are shown (n=6 retinas per
experimental condition). Blots were quantified by
performing scanning densitometry, and results are
means±s.e.m. *P≤0.05, Igf1−/− vs Igf1+/+ mice
matched at each age (two-way ANOVA followed by
Bonferroni t-test). / indicates the ratio between the
two indicated proteins, and the fold change relative
to Igf1+/+ mice is shown.
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autophagy in retinas from old Igf1−/− mice. Interestingly, two-way
ANOVA analysis showed significant differences in these
parameters when comparisons were made between the two ages
(old vs young; data not shown) and between genotypes (Igf1−/− vs
Igf1+/+).
Ultrastructural features of altered autophagy in the retinas
of Igf1−/−mice
To further assess the alteration of the autophagic activity during
ageing in the retina of Igf1−/− mice, we examined retinal sections
with transmission electron microscopy (TEM). We found in the
retina of both mouse genotypes double- and multiple-membraned
vacuoles containing electron-dense materials or whorls of
membranous material, which are properties of autophagosomes
(Klionsky et al., 2016) (Fig. 7A). We focused on the analysis of
the number of autophagosomes located in the INL and OPL –
layers in which inflammatory processes have been detected.
Autophagosomes were seen in the cytoplasm of the cells from the
INL and were scattered in the dendrites of those cells in the OPL.
The average number of autophagosomes in the cytoplasm of cells
located at the INL was 3.83/50 mm2 in Igf1+/+ mice compared to
8.12/50 mm2 in Igf1−/− mice, and the average number of
Fig. 3. Analysis of the autophagic flux in retinas from young Igf1−/−mice. (A) Atg9, Atg5, Atg 4 and Bcn1mRNA levels in retinas from young (Y) Igf1−/− and
Igf1+/+ mice (n=6 retinas per genotype). (B) Protein extracts (30 μg) from retinas from young (Y) Igf1−/− and Igf1+/+ mice were separated by SDS-PAGE and
analyzed by western blotting with antibodies against LC3, p62 and phosphorylated mTOR. α-Tubulin was used as a loading control. Three samples from different
mice are shown for each genotype and age. Representative autoradiograms are shown (n=6 retinas per genotype). The blots were quantified by performing
scanning densitometry, and results are means±s.e.m. *P≤0.05, Igf1−/− vs Igf1+/+ mice (two-way ANOVA followed by Bonferroni t-test). / indicates the ratio
between the two indicated proteins, and the fold change relative to Igf1+/+ (Y) is shown.
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autophagosomes in the OPL was 3.66/50 mm2 in Igf1+/+ mice in
comparison to 6.16/50 mm2 in Igf1−/− mice (Fig. 7B).
Reactive gliosis in Igf1−/−mice occurs during ageing
In an attempt to correlate the retinal and visual alterations of Igf1−/−
mice during ageing with persistent unresolved neuroinflammation,
we evaluated the glial activation in the retina. Reactive gliosis in
macroglia was monitored by the expression of glial fibrillar acidic
protein (GFAP). As depicted in Fig. 8, strong GFAP
immunostaining was detected in sections of retinas from old
Igf1−/− mice, particularly between the IPL and OPL, whereas
the signal was very weak in retinas from Igf1+/+ mice at the
same age.
DISCUSSION
IGF-1 is a neurotrophic and anti-apoptotic factor in the CNS (Guan,
2008). Therefore, the research on IGF-1 actions during neuronal
injuries is of great relevance because it could provide opportunities
to develop therapeutic approaches to combat neural diseases. IGF-1
enhances neuronal metabolism (Bondy and Cheng, 2002),
modulates neuronal excitability (Carro et al., 2000) and also
elicits anti-apoptotic, antioxidant and anti-inflammatory roles
(Higashi et al., 2010). Very recently, it has been demonstrated
that brain-derived IGF-1 plays a crucial role during postnatal
hippocampal neurogenesis (Nieto-Estevez et al., 2016). Deficiency
in the IGF1 gene in humans is associated with neuronal disorders
such as microcephaly, mental retardation and bilateral sensorineural
deafness (Woods et al., 1996; Walenkamp et al., 2005; Netchine
et al., 2009).
We have reported that Igf1−/− mice have progressive loss their
visual function; these animals being almost blind at 12 months of
age. This loss of visual function correlates with structural alterations
in the first synapse of the retinal pathway and affects the
postsynaptic transduction from horizontal and bipolar cells
located between the INL and OPL. However, photoreceptor cell
number was unaffected by Igf1 deletion in this mouse model of
syndromic deafblindness (Rodriguez-de la Rosa et al., 2012).
Moreover, we have recently demonstrated that the enhancement of
IGF1R-mediated signaling through inhibition of protein tyrosine
phosphatase 1B conferred protection against inflammation-
mediated reactive gliosis in the retina (Arroba and Valverde,
2015). Based on these previous findings, in this study we analyzed
the inflammatory context in the retina of Igf1−/− mice at two ages –
6 months apart – which revealed marked differences in retinal
structure and visual function. Notably, increased mRNA levels of
proinflammatory cytokines (TNFα and IL1β) were detected in the
retinas from Igf1−/− mice at 6 months of age, indicating that an
incipient proinflammatory status is established before alterations in
both retinal synapses and visual function can be detected.
Importantly, inflammation remained elevated in old Igf1−/− mice,
reflecting a persistent proinflammatory environment in their retinas.
At the molecular level, inflammation was evidenced by increased
Fig. 4. Analysis of the inflammasome complex
in retinas from old Igf1−/−mice. (A) Nlrp3mRNA
levels in retinas from old (O) Igf1−/− and Igf1+/+
mice. Results are means±s.e.m. (n=6 retinas per
genotype). (B) Protein extracts (30 μg) of retinas
from old (O) Igf1−/− and Igf1+/+ mice were
separated by SDS-PAGE and analyzed by western
blotting with an antibody against IL1β. α-Tubulin
was used as a loading control. Three samples from
different mice are shown for each genotype and
age. Representative autoradiograms are shown
(n=6 retinas per genotype). The blots were
quantified by performing scanning densitometry,
and results are means± s.e.m. *P≤0.05, Igf1−/− vs
Igf1+/+ mice (two-way ANOVA followed by
Bonferroni t-test). Fold changes relative to Igf1+/+
(O) mice are shown. (C) Immunostaining for
caspase-1 (fragment p10; green), and cells were
counterstained with DAPI (blue). Representative
images are shown. GCL, ganglion cell layer; INL,
inner nuclear layer; ONL, outer nuclear layer.
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JNK and p38 MAPK phosphorylation in the retinas of Igf1−/−mice
at both ages. Based on these results, we hypothesized that the
chronic inflammatory status in the retina of Igf1−/−mice at the age of
6 months might be an initial trigger for the retinal and visual defects
detected later on. Taking a step further, the activity of the
inflammasome system, monitored by examining the mRNA levels
of Nlrp3, processing of pro-IL1β and the immunostaining of the
active fragment of caspase-1 (p10) in the INL, was found to be
elevated exclusively in the retinas of old Igf1−/−mice. Therefore, in
the retinas of young Igf1−/− mice, protective mechanisms might
account for the defence against neuroinflammation.
The relationship between IGF-1 and autophagy is becoming a
focus of research in the field of neurodegeneration. In fact, little
attention has been previously paid to the role of IGF-1 in promoting
cell survival against excitotoxicity, which is always associated with
the early stages of injury (Troncoso et al., 2014), through regulation
of autophagy. Autophagy is a highly sensitive cellular process
induced in response to a wide range of stressful conditions in order
to maintain homeostasis. Among them, prolonged exposure of
tissues and organs to high concentrations of inflammatory mediators
represents a stressful environment and can result in severe damage
(Cook et al., 2004). Because abnormal inflammation could disrupt
cellular homeostasis, autophagy contributes to dampening of
inflammatory responses (Lapaquette et al., 2015). Our results
clearly showed that, in mice that lack Igf1−/−, the autophagic flux,
monitored by measuring the mRNA levels of autophagy-related
genes and LC3-II and p62 protein levels, was enhanced at 6 months
of age, a time at which synaptic connectivity in the retina and visual
function are well preserved (Rodriguez-de la Rosa et al., 2012).
These data are reinforced by the absence of activation of the
inflammasome system in the retina despite the increased mRNA
levels of Tnfa and Il1b. Regarding IL1β, although its mRNA levels
were higher in the retinas of young Igf1−/− mice compared to those
in their age-matched wild-type counterparts, the absence of
activation of the inflammasome system is likely to prevent IL1β
processing (Sutterwala et al., 2006). It is intriguing how Igf1
deficiency is able to trigger autophagy as a protective mechanism
that is aimed at preserving retinal structure and visual function.
This response deserves further research in the context of
neurodegeneration. Based on that, therapies aimed at increasing
the autophagic flux are promising in order to prevent the progression
of neurodegenerative diseases, particularly those affecting the retina
(Rodriguez-Muela et al., 2015).
The opposite situation was detected in retinas of old Igf1−/− mice.
In those mice, the activation of the inflammasome (increased Nlrp3
mRNA, immunolabelling of active caspase-1 and IL1β processing)
Fig. 5. Increased number of activated
microglia cells in retinas from old
Igf1−/− mice. Immunostaining (A) and
quantification of Cd11b- (red) and Iba-1-
(green) positive cells counterstained with
DAPI (blue) in retinas from old (O) Igf1−/−
and Igf1+/+ mice. GCL, ganglion cell layer.
The results are means±s.e.m. *P≤0.05,
Igf1−/− vs Igf1+/+ mice (two-way ANOVA
followed by Bonferroni t-test). Arrows point
to enlarged images of the indicated areas.
(B) Protein extracts (30 μg) of retinas from
old (O) Igf1−/− and Igf1+/+ mice were
separated by SDS-PAGE and analyzed
by western blotting with the antibody
against Iba-1. α-Tubulin was used as a
loading control. Three samples from
different mice are shown for each
genotype and age. Representative
autoradiograms are shown (n=6 retinas
per genotype). The blots were quantified
by performing scanning densitometry, and
the results are means±s.e.m. *P≤0.05,
Igf1−/− vs Igf1+/+ mice (two-way ANOVA
followed by Bonferroni t-test). Fold
changes relative to Igf1+/+ (O) are shown.
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coincided with the blockade of the autophagic flux, which was
revealed by elevations in mTOR phosphorylation and p62 levels in
whole retinal extracts. Confirmation of these results was obtained
with TEM analysis that revealed the accumulation of
autophagosomes in the INL and OPL layers of the retina in Igf1−/−
mice at the age of 12 months. Because our previous work
demonstrates that, in these layers, neural synapsis is disrupted
(Rodriguez-de la Rosa et al., 2012), we can hypothesize that, in
neuronal cells of the INL and OPL, autophagy might be necessary to
preserve photoreceptor connectivity in the retina (Shen et al., 2015), a
process which is likely to be negatively affected by the
proinflammatory environment. Interestingly, the accumulation of
autophagosomes in these layers is coincident with the presence of
activated (amoeboid)microglia. It iswell known that in healthy retina,
ramified microglia cells (Cd11b+) are constantly involved in the
surveillance of the retinal layers by releasing neuroprotective and anti-
inflammatory factors (Streit, 2002; Arroba et al., 2011; Zabel and
Kirsch, 2013). However, in response to a persistent proinflammatory
stimuli, the chronically activated amoeboid-shaped microglia can
induce neuroinflammation by releasing a plethora of cytokines
(Block et al., 2013; Mosher andWyss-Coray, 2014). Our results have
revealed that, in the retina of old Igf1−/− mice, activated amoeboid
microglia (Iba-1+) are present to a higher extent than in age-matched
wild-type mice, showing a distribution pattern around the IPL, OPL
and INL. As stated above, these are the crucial layers where cells that
are responsible for the amplification of the synaptic transmission and
that are highly sensitive to the inflammatory environment are located.
Therefore, the inhibition of the autophagic processes in the retina
from old Igf1−/− mice could explain the advanced state of retinal
gliosis in these mice, which is a hallmark of neurodegeneration (Xing
et al., 2012; Arroba et al., 2014).
In conclusion, this study provides new evidence regarding the
effect of Igf1 deficiency on the blockade of autophagy in the retina
that is related to neuroinflammation. Our results pinpoint
autophagy as an adaptive response that might confer protection
against the persistent activation of the inflammasome and
Fig. 6. Decreased autophagy flux in the
retina from old Igf1−/− mice. (A) Atg9,
Atg5, Atg4 and Bcn1 mRNA levels in
retinas from old (O) Igf1−/− and Igf1+/+
mice (n=5 retinas per genotype).
(B) Protein extracts (30 μg) of retinas from
old (O) Igf1−/− and Igf1+/+ mice were
separated by SDS-PAGE and analyzed
by western blotting with antibodies against
LC3, p62, phosphorylated (p)-mTOR and
mTOR. α-Tubulin was used as a loading
control. Three samples from different mice
are shown for each genotype and age.
Representative autoradiograms are
shown (n=6 retinas per genotype). The
blots were quantified by performing
scanning densitometry. The results of
panels A and B are means±s.e.m.
*P≤0.05, Igf1−/− vs Igf1+/+ age-matched
mice (two-way ANOVA followed by
Bonferroni t-test). / indicates the ratio
between the two indicated proteins, and
the fold change relative to Igf1+/+ (O) mice
is shown.
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microglia in the retina during ageing, therefore protecting against
deterioration of the retinal synapses and visual function. In this
scenario, malfunction of aged microglia can trigger a chronic low-
grade inflammatory environment that favours the onset and
progression of retinal degeneration.
MATERIAL AND METHODS
Mouse handling and genotyping
Heterozygous mice with a targeted disruption of the Igf1 gene were bred
andmaintained on a hybridMF1 and 129/sv genetic background to increase
survival of nullizygous Igf1mutants (Liu et al., 1993). Themortality of null
mice before adulthood is high, although between 20 and 30% of mice
survive after birth. Male and female wild-type (Igf1+/+) and null (Igf1−/−)
mice were studied at 6 and 12 months of age. The latter was the oldest age
studied because Igf1−/− mice become totally deaf and blind at this age
(Rodriguez-de la Rosa et al., 2012). Hearing was assessed by auditory
brainstem recording in the mice, as described previously (data not shown)
(Cediel et al., 2006). Mouse genotypes were identified as previously
described (Sanchez-Calderon et al., 2010). Mice were fed tap water,
standard diet and housed following recommendations of Federation of
European Laboratory Animal Science Associations. All animal
experimentation was conducted in accordance with Spanish and
European legislation (EU directive 2010/63/EU) and approved by the
Animal Care and Use Committee of Spanish National Research Council
[Consejo Superior de Investigaciones Científicas (CSIC)]. The number of
retinas used in each experimental approach, obtained from different mice, is
indicated in the figure legends.
Isolation of retina
Animals were killed by cervical dislocation, and eyes were enucleated. The
lens, anterior segment, vitreous body, retinal pigment epithelium and sclera
were removed, and the retinawas immediately frozen at−80°C for protein or
RNA extraction later.
Quantitative real-time PCR analysis
Total RNA was extracted with Trizol® reagent (Invitrogen, Madrid, Spain)
and reverse transcribed using a SuperScript™ III First-Strand Synthesis
System for quantitative real-time PCR (RT-qPCR) following the
manufacturer’s indications (Invitrogen). Quantitative PCR was performed
with an ABI 7900 sequence detector. Primer-probe sets for mouse Tnfa, Il6,
Il1b, Nlrp3, Nos2, Arg1, Atg9, Atg5, Atg4, Bcn1 and 18s were purchased as
pre-designed TaqMan gene expression assays (Applied Biosystems).
Fig. 7. Accumulation of autophagosomes in retinas from old Igf1−/−mice.
(A) In these representative TEM images, typical autophagosomes can be
identified by the presence of double membranes in retinas from old (O) Igf1−/−
and Igf1+/+ mice. Scale bar: 2 µm. (B) The autophagosomes were counted in
ten fields per mouse (n=3 mice per genotype). The results are means±s.e.m.
*P≤0.05, Igf1−/− vs Igf1+/+ age-matched mice at the inner nuclear layer (INL).
&P≤0.05, Igf1−/− vs Igf1+/+ age-matched mice at the outer plexiform layer
(OPL). ONL, outer nuclear layer.
Fig. 8. Reactive gliosis is increased in the retinas from old Igf1−/− mice.
Retinal sections from young (Y) and old (O) Igf1−/− and Igf1+/+ mice were
immunolabelled for GFAP (green) and counterstained with DAPI (blue).
Representative images are shown. Merged images are shown on the left,
GFAP-only images are shown on the right.
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Western blotting
Whole retinas were homogenized in lysis buffer containing 50 mMTris-HCl,
pH 7.4, 150 mMNaCl, 1 mMNa3VO4, 1 mMNaF, 1 mMEGTA, 15% (w/v)
NP40 and 0.25% (w/v) sodium deoxycholate, supplemented with protease
inhibitors (10 µg/ml leupeptin, 10 µg/ml aprotinin and 100 µg/ml
phenylmethylsulphonyl fluoride). All debris was removed by centrifugation
at 14,000 g for 10 min at 4°C, and protein concentration was quantified using
the Bio-Rad protein assay with BSA as a standard. Equivalent amounts of
protein were resolved using denaturing sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE), followed by transfer to
PVDF membranes (Bio-Rad). Membranes were blocked using 5% non-fat
driedmilk or 3%BSA in 10 mMTris-HCl, 150 mMNaCl, pH 7.5 (TBS), and
incubated overnight with several antibodies (1:2000 unless otherwise stated)
in 0.05% Tween-20 in TBS. Immunoreactive bands were visualized using the
enhanced chemiluminescence reagent (Bio-Rad). Primary antibodies against
caspase-1 (p10) (#sc-514), iNOS (sc-650), JNK (#sc-571), phosphorylated
p38 MAPK (at residues Thr180 and Tyr182) (sc-17852-R) and p38 MAPK
(sc-9212) were purchased from Santa Cruz Biotechnology. Anti-
phosphorylated-JNK (at Thr183 and Tyr185) (#4668), p62 (#5114) and
LC3 (#2775) antibodies were purchased from Cell Signaling Technology.
Anti-Iba-1 (#ab5076) and anti-Cd11b (#ab8878) antibodies were from
Abcam.Anti-GFAPantibody (#z0334) was obtained fromDAKOand anti-α-
tubulin (#T-5168) antibody was from Sigma Chemical Co.
Immunofluorescence
Eyes were fixed in 4% paraformaldehyde for 24 h at 4°C and infiltrated with
sucrose 25% (w/v). For immunofluorescence analysis, retinal cryosections
were washed in TBS containing 0.1% (w/v) BSA and 0.1% (v/v) Triton
X-100 (this buffer was used for all subsequent washes), and then blocked
and permeabilized for 2 h in TBS containing 3% (w/v) BSA and 1% (v/v)
Triton X-100. The sections were then incubated overnight in a humid
chamber at 4°C with rabbit anti-GFAP (1:250), goat anti-Iba-1 (1:100), rat
anti-Cd11b (1:250) and rabbit anti-caspase-1 (1:100) antibodies in blocking
solution. Sections were washed and incubated for 90 min with anti-rabbit,
anti-goat or anti-rat immunoglobulin antibodies conjugated to Alexa-647 or
-488 (1:2000; Molecular Probes). After washing, sections were mounted
with medium (Fluoromount G) containing 4-6-diamidino-2-phenylindole
(DAPI). Staining was observed with an inverted laser confocal microscope
LSM710 (Carl Zeiss Microscopy GmbH).
Microscopy and cell quantification
Images were acquired by using confocal microscopy, and stained cells or
nuclei were scored by two observers that had been blinded to the
experiment. Stained nuclei of microglial-positive cells were counted in
the indicated retinal layers of an entire section of the retina using a 40×
objective. At least three retinas and four nonadjacent sections per retina were
scored for each experimental point.
Transmission electron microscopy
Eyes were dissected, fixed in 2% glutaraldehyde in phosphate or cacodylate
buffer, postfixed in osmium tetroxide and embedded in araldite. For light
microscopy, semi-thin sections were obtained and stained with Toluidine
Blue. For TEM analysis, ultrathin sections were stained with lead citrate and
examined with a JEOL1011 electron microscope. Quantification of the
double-membraned vacuole-like structure was performed by counting the
autophagosomes in 50 micrographs (2500 μm2 total). The total number of
these structures, overlying at least one intersection of a Photoshop-generated
grid, was counted.
Statistical analysis
Densitometry analysis of the western blots was performed using the ImageJ
program. Values in all graphs represent the mean±s.e.m. Statistical tests
were performed using SPSS 21.0 for Windows (SPSS Inc. IBM). Data were
analyzed by using one-way or two-way ANOVA followed by Bonferroni
t-test. Differences were considered significant at P≤0.05.
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